2. 您的位置
3. 首页
4. 会议论文
5. No Woman Lost to Follow-Up

No Woman Lost to Follow-Up

来源 :The 6th Biennial Conference of Asia Oceania Research Organis | 被引量 : 0次 | 上传用户：A58400794

【摘 要】

：

Whether in clinical trials, prospective cohort studies, or routine screening programs, too many individuals are categorized as "lost to follow-up".How can we prevent the "loss" of these people?

【作 者】

：

Edward L.Trimble 

【机 构】

：

National Cancer Institute,National Institutes of Health,Department of Health and Human Services,USA

【出 处】

：

The 6th Biennial Conference of Asia Oceania Research Organis

【发表日期】

：

2014年2期

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

Whether in clinical trials, prospective cohort studies, or routine screening programs, too many individuals are categorized as "lost to follow-up".How can we prevent the "loss" of these people?

其他文献

Comparison of HPV genotypes and viral load between different sites of the entire genital tract the s

Objectives: To compare the consistency of HPV genotype and viral loads among different sites within the female genital tract, and to correlate these with clinical outcomes.

会议

THE FIRST VACCINE AND CERVICAL CANCER SCREEN PROJECT (VACCS1): COMBINING THE HPV-VACCINE AND SELF-SC

Background Cervical cancer is preventable but still highly prevalent in South Africa.New strategies to implement effective primary and secondary prevention technologiesinto the developing world are ur

会议

Characterization of Clonality and the effects of host genetic background on HPV DNA induced human ke

HPV immortalized human keratinocytes vary in cell morphology, growth properties,resistance to inducers of terminal differentiation, and karyotype.

会议

Recent Progress of HPV therapeutic vaccine in cervical neoplasia

Persistent human papillomavirus(HPV) infections, in particular HPV genotypes 16 and 18, are associated with the development of cervical dysplasia and cancer.

会议

Cancer Immunoprevention for Cervical Cancer Prevention

Human papillomavirus (HPV) is responsible for nearly all cervical cancer cases (99.7％) and an estimated 5％ of all cancers worldwide.Recently, HPV associated orophryngeal cancers are also on the rise.

会议

WOMEN'S HEALTH INITIATIVE IN CHINA-CERVICAL CANCER PREVENTION PROGRAM Cervical Cancer Preventio

Objectives:There are 135,000 new cases of cervical cancer in China every year and the screening rate is less than 60％.

会议

Health Economic Evaluation of Primary Human Papillomavirus Screening in Urban Populations in China

Background:Most women in urban populations in China do not have access to cervical screening and the role of HPV in screening low resource urban women has not been clarified.Objectives: To quantify ef

会议

budgetary controlChinaeconomicshuman papillomavirusmass screeningmathematic

When and How to Do a Colposcopic Examination

Colposcopy plays a central role in cervical cancer prevention.With the increasing knowledge about etiology and pathogenesis of cervical disease, the role of colposcopy is far more than to identify the

会议

HPV Vaccine Clinical Trial Update-from Global to Asia

After 10 years since the first clinical trial of the HPV vaccines, new long-term data is now available particularly in the areas of long-term vaccine effectiveness and safety.

会议

HPV vaccination and its impact on cervical screening in Australia and New Zealand

Australia and New Zealand (NZ) both have successful organised national cervical screening programs, both established in 1991, which in both countries have resulted in significant reductions in cervica

会议